Reconsidering America’s Childhood Vaccine Recommendations

Childhood vaccines have somehow become one more subject that Americans are expected to discuss while wearing political jerseys. Question the government too aggressively, and one side calls you an anti-science crank. Defend established vaccines too confidently, and the other side assumes you receive handwritten Christmas cards from pharmaceutical executives. Such is the calm, reasonable state…

The GOP’s Planned Parenthood Fumble

Planned Parenthood is back to billing Medicaid for non-abortion services after a one-year federal reimbursement ban expired in early July 2026. That has pro-life groups furious, Planned Parenthood relieved, and Republican lawmakers once again discovering that campaign promises are much easier to shout into a microphone than to turn into durable law. Funny how that…

The Federal Marijuana Pivot

For decades, the federal government treated marijuana like it belonged in the same category as the most dangerous drugs on the planet: no medical value, high abuse potential, end of discussion. That stance held firm even as states legalized it, doctors prescribed it, and millions of Americans quietly (or not so quietly) incorporated it into…

Medicare by Choice: Smart Reform or Slow-Motion Takeover?

At its core, “Medicare by Choice” is an attempt to thread one of the most politically delicate needles in American policy: how to expand access to affordable healthcare without detonating the existing system in the process. Instead of replacing private insurance outright, the proposal would allow any American—regardless of age—to voluntarily enroll in Medicare. Employers…

Power, Pressure, and President Trump’s Pharma Deal

President Trump’s agreement with major pharmaceutical companies to reduce drug prices deserves more than a quick partisan reaction. It sits at the crossroads of health-care economics, executive power, and moral responsibility, and it raises a question Americans should keep asking long after the headlines fade: will this actually help patients, or is it merely another…

Why Cutting Federal Funding for Gender-Affirming Care Is the Right and Necessary Step

The federal government’s recent move to restrict Medicare and Medicaid funding for so-called “gender-affirming care” for minors has ignited predictable outrage. Activists describe it as discriminatory. Advocacy groups frame it as a moral emergency. Critics accuse policymakers of ignoring “settled science.” But beneath the noise is a quieter, more sobering reality: for the first time…

A Reflection on the GOP’s Health-Care Rift

Washington, D.C., never lacks for drama, but every now and then the Republican caucus serves up an episode spicy enough to make daytime television blush. This time, the plot centers on something far more consequential than committee assignments or who accidentally unplugged the espresso machine in the Capitol cafeteria. House Republicans have found themselves in…